Krystal Biotech (KRYS) Prepaid Assets (2016 - 2026)
Krystal Biotech (KRYS) reported Prepaid Assets of $10.6 million for Q1 2026, down 36.47% on a YoY basis from $16.8 million in Q1 2025, and down 24.02% sequentially from $14.0 million in Q4 2025.
Krystal Biotech (KRYS) Prepaid Assets (2016 - 2026) Analysis & Trends
Krystal Biotech (KRYS) has 11 years of Prepaid Assets data on file, last reported at $10.6 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 36.47% year-over-year to $10.6 million; the trailing twelve-month figure through Mar 2026 stood at $10.6 million (down 36.47% YoY), and the FY2025 full-year result was $14.0 million, up 766.17% from the prior year.
- Prepaid Assets eased to $10.6 million in Q1 2026, from $14.0 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $17.2 million in Q3 2025 to a low of $1.6 million in Q4 2024.
- A 5-year average of $8.1 million and a median of $6.5 million in 2023 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets slumped 75.89% in 2024 and surged 766.17% in 2025, its largest moves.
- Tracing KRYS's Prepaid Assets over 5 years: stood at $4.6 million in 2022, then surged by 45.53% to $6.7 million in 2023, then tumbled by 75.89% to $1.6 million in 2024, then surged by 766.17% to $14.0 million in 2025, then dropped by 24.02% to $10.6 million in 2026.
- Business Quant data shows KRYS's Prepaid Assets at $10.6 million in Q1 2026, $14.0 million in Q4 2025, and $17.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Krystal Biotech | 9.59 Bn | 8.77 Bn | 110.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.64 Mn |
| Dec 31, 2025 | 14.01 Mn |
| Sep 30, 2025 | 17.21 Mn |
| Jun 30, 2025 | 16.88 Mn |
| Mar 31, 2025 | 16.75 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | 8.96 Mn |
| Jun 30, 2024 | 7.75 Mn |
| Mar 31, 2024 | 6.49 Mn |
| Dec 31, 2023 | 6.71 Mn |
| Sep 30, 2023 | 5.47 Mn |
| Jun 30, 2023 | 6.49 Mn |
| Mar 31, 2023 | 5.04 Mn |
| Dec 31, 2022 | 4.61 Mn |
| Sep 30, 2022 | 3.16 Mn |
| Jun 30, 2022 | 3.21 Mn |
| Mar 31, 2022 | 3.37 Mn |
| Dec 31, 2021 | 4.17 Mn |
| Sep 30, 2021 | 2.72 Mn |
| Jun 30, 2021 | 2.20 Mn |